Device Authority strengthens position in machine identity and Zero Trust Security

Tern plc

Device Authority has been named as a representative vendor for IoT Authentication in two Gartner Hype Cycle reports for 2026, covering Digital Identity and Zero-Trust Technology.

The recognition supports the company’s positioning in machine identity security, certificate lifecycle automation and cryptographic trust. These areas are becoming more important as organisations manage growing numbers of connected devices, operational systems and software workloads.

Device Authority’s KeyScaler platform is designed to automate machine identity provisioning, certificate lifecycle management, cryptographic key management and security policy enforcement. The technology is used to establish and maintain trust between devices and systems without relying on manual processes.

This is particularly relevant in environments where large numbers of connected assets need to be authenticated and managed securely. These include industrial systems, operational technology, medical devices, connected products and automotive platforms.

As organisations adopt Zero Trust security models, machine identity becomes a more important part of access control. Zero Trust requires every user, device and system to be verified before access is granted. That increases the need for reliable digital identities and automated management of the certificates and keys that support them.

Device Authority’s technology addresses this requirement by helping organisations control machine identities at scale. Automation can reduce the risk associated with expired certificates, unmanaged credentials and inconsistent security policies across large device estates.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Search